Global Peripheral Arterial Disease (PAD) Therapeutics Market Size, Status and Forecast 2020-2026

Publisher Name :
Date: 31-Jul-2020
No. of pages: 94
Inquire Before Buying

Peripheral Arterial Disease (PAD) Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Peripheral Arterial Disease (PAD) Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study

- AstraZeneca Plc. (UK)

- Bayer HealthCare Pharmaceuticals (Germany)

- Bristol-Myers Squibb Company (US)

- Merck & Co., Inc. (US)

- Proteon Therapeutics, Inc. (US)

- Sanofi S.A. (France)

- Symic Bio, Inc. (US)

- TheraVasc Inc. (US)

- AnGes MG, Inc. (Japan)

- Athersys, Inc. (US)

- Betagenon AB (Sweden)

- miRagen Therapeutics, Inc. (US)

- Multi Gene Vascular Systems Ltd (Israel)

- ViroMed Co. Ltd. (Korea)

Market segment by Type, the product can be split into

- Anti-Platelet Drugs

- Dual Antiplatelet Therapy Drugs

- Others

Market segment by Application, split into

- Hospitals

- Clinics

- Others

Market segment by Regions/Countries, this report covers

- North America

- Europe

- China

- Japan

- Southeast Asia

- India

- Central & South America

Global Peripheral Arterial Disease (PAD) Therapeutics Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Peripheral Arterial Disease (PAD) Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Anti-Platelet Drugs
1.4.3 Dual Antiplatelet Therapy Drugs
1.4.4 Others
1.5 Market by Application
1.5.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Perspective (2015-2026)
2.2 Global Peripheral Arterial Disease (PAD) Therapeutics Growth Trends by Regions
2.2.1 Peripheral Arterial Disease (PAD) Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Peripheral Arterial Disease (PAD) Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Peripheral Arterial Disease (PAD) Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Peripheral Arterial Disease (PAD) Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Peripheral Arterial Disease (PAD) Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Peripheral Arterial Disease (PAD) Therapeutics Players by Market Size
3.1.1 Global Top Peripheral Arterial Disease (PAD) Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Concentration Ratio
3.2.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Peripheral Arterial Disease (PAD) Therapeutics Revenue in 2019
3.3 Peripheral Arterial Disease (PAD) Therapeutics Key Players Head office and Area Served
3.4 Key Players Peripheral Arterial Disease (PAD) Therapeutics Product Solution and Service
3.5 Date of Enter into Peripheral Arterial Disease (PAD) Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Peripheral Arterial Disease (PAD) Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Peripheral Arterial Disease (PAD) Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2015-2020)
5.2 Global Peripheral Arterial Disease (PAD) Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Peripheral Arterial Disease (PAD) Therapeutics Market Size (2015-2020)
6.2 Peripheral Arterial Disease (PAD) Therapeutics Key Players in North America (2019-2020)
6.3 North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2015-2020)
6.4 North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size (2015-2020)
7.2 Peripheral Arterial Disease (PAD) Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2015-2020)
7.4 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Peripheral Arterial Disease (PAD) Therapeutics Market Size (2015-2020)
8.2 Peripheral Arterial Disease (PAD) Therapeutics Key Players in China (2019-2020)
8.3 China Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2015-2020)
8.4 China Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Peripheral Arterial Disease (PAD) Therapeutics Market Size (2015-2020)
9.2 Peripheral Arterial Disease (PAD) Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2015-2020)
9.4 Japan Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Market Size (2015-2020)
10.2 Peripheral Arterial Disease (PAD) Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Peripheral Arterial Disease (PAD) Therapeutics Market Size (2015-2020)
11.2 Peripheral Arterial Disease (PAD) Therapeutics Key Players in India (2019-2020)
11.3 India Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2015-2020)
11.4 India Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Peripheral Arterial Disease (PAD) Therapeutics Market Size (2015-2020)
12.2 Peripheral Arterial Disease (PAD) Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 AstraZeneca Plc. (UK)
13.1.1 AstraZeneca Plc. (UK) Company Details
13.1.2 AstraZeneca Plc. (UK) Business Overview
13.1.3 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Introduction
13.1.4 AstraZeneca Plc. (UK) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020))
13.1.5 AstraZeneca Plc. (UK) Recent Development
13.2 Bayer HealthCare Pharmaceuticals (Germany)
13.2.1 Bayer HealthCare Pharmaceuticals (Germany) Company Details
13.2.2 Bayer HealthCare Pharmaceuticals (Germany) Business Overview
13.2.3 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Introduction
13.2.4 Bayer HealthCare Pharmaceuticals (Germany) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020)
13.2.5 Bayer HealthCare Pharmaceuticals (Germany) Recent Development
13.3 Bristol-Myers Squibb Company (US)
13.3.1 Bristol-Myers Squibb Company (US) Company Details
13.3.2 Bristol-Myers Squibb Company (US) Business Overview
13.3.3 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Introduction
13.3.4 Bristol-Myers Squibb Company (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020)
13.3.5 Bristol-Myers Squibb Company (US) Recent Development
13.4 Merck & Co., Inc. (US)
13.4.1 Merck & Co., Inc. (US) Company Details
13.4.2 Merck & Co., Inc. (US) Business Overview
13.4.3 Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Introduction
13.4.4 Merck & Co., Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020)
13.4.5 Merck & Co., Inc. (US) Recent Development
13.5 Proteon Therapeutics, Inc. (US)
13.5.1 Proteon Therapeutics, Inc. (US) Company Details
13.5.2 Proteon Therapeutics, Inc. (US) Business Overview
13.5.3 Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Introduction
13.5.4 Proteon Therapeutics, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020)
13.5.5 Proteon Therapeutics, Inc. (US) Recent Development
13.6 Sanofi S.A. (France)
13.6.1 Sanofi S.A. (France) Company Details
13.6.2 Sanofi S.A. (France) Business Overview
13.6.3 Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Introduction
13.6.4 Sanofi S.A. (France) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020)
13.6.5 Sanofi S.A. (France) Recent Development
13.7 Symic Bio, Inc. (US)
13.7.1 Symic Bio, Inc. (US) Company Details
13.7.2 Symic Bio, Inc. (US) Business Overview
13.7.3 Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Introduction
13.7.4 Symic Bio, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020)
13.7.5 Symic Bio, Inc. (US) Recent Development
13.8 TheraVasc Inc. (US)
13.8.1 TheraVasc Inc. (US) Company Details
13.8.2 TheraVasc Inc. (US) Business Overview
13.8.3 TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Introduction
13.8.4 TheraVasc Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020)
13.8.5 TheraVasc Inc. (US) Recent Development
13.9 AnGes MG, Inc. (Japan)
13.9.1 AnGes MG, Inc. (Japan) Company Details
13.9.2 AnGes MG, Inc. (Japan) Business Overview
13.9.3 AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Introduction
13.9.4 AnGes MG, Inc. (Japan) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020)
13.9.5 AnGes MG, Inc. (Japan) Recent Development
13.10 Athersys, Inc. (US)
13.10.1 Athersys, Inc. (US) Company Details
13.10.2 Athersys, Inc. (US) Business Overview
13.10.3 Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Introduction
13.10.4 Athersys, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020)
13.10.5 Athersys, Inc. (US) Recent Development
13.11 Betagenon AB (Sweden)
10.11.1 Betagenon AB (Sweden) Company Details
10.11.2 Betagenon AB (Sweden) Business Overview
10.11.3 Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Introduction
10.11.4 Betagenon AB (Sweden) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020)
10.11.5 Betagenon AB (Sweden) Recent Development
13.12 miRagen Therapeutics, Inc. (US)
10.12.1 miRagen Therapeutics, Inc. (US) Company Details
10.12.2 miRagen Therapeutics, Inc. (US) Business Overview
10.12.3 miRagen Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Introduction
10.12.4 miRagen Therapeutics, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020)
10.12.5 miRagen Therapeutics, Inc. (US) Recent Development
13.13 Multi Gene Vascular Systems Ltd (Israel)
10.13.1 Multi Gene Vascular Systems Ltd (Israel) Company Details
10.13.2 Multi Gene Vascular Systems Ltd (Israel) Business Overview
10.13.3 Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Introduction
10.13.4 Multi Gene Vascular Systems Ltd (Israel) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020)
10.13.5 Multi Gene Vascular Systems Ltd (Israel) Recent Development
13.14 ViroMed Co. Ltd. (Korea)
10.14.1 ViroMed Co. Ltd. (Korea) Company Details
10.14.2 ViroMed Co. Ltd. (Korea) Business Overview
10.14.3 ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Introduction
10.14.4 ViroMed Co. Ltd. (Korea) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020)
10.14.5 ViroMed Co. Ltd. (Korea) Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Peripheral Arterial Disease (PAD) Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Peripheral Arterial Disease (PAD) Therapeutics Revenue
Table 3. Ranking of Global Top Peripheral Arterial Disease (PAD) Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Anti-Platelet Drugs
Table 6. Key Players of Dual Antiplatelet Therapy Drugs
Table 7. Key Players of Others
Table 8. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Regions (2015-2020)
Table 12. Global Peripheral Arterial Disease (PAD) Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Peripheral Arterial Disease (PAD) Therapeutics Market Growth Strategy
Table 18. Main Points Interviewed from Key Peripheral Arterial Disease (PAD) Therapeutics Players
Table 19. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 20. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Players (2015-2020)
Table 21. Global Top Peripheral Arterial Disease (PAD) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peripheral Arterial Disease (PAD) Therapeutics as of 2019)
Table 22. Global Peripheral Arterial Disease (PAD) Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Peripheral Arterial Disease (PAD) Therapeutics Product Solution and Service
Table 25. Date of Enter into Peripheral Arterial Disease (PAD) Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 28. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Type (2015-2020)
Table 29. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Type (2021-2026)
Table 30. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Application (2015-2020)
Table 31. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 32. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Application (2021-2026)
Table 33. North America Key Players Peripheral Arterial Disease (PAD) Therapeutics Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Peripheral Arterial Disease (PAD) Therapeutics Market Share (2019-2020)
Table 35. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 36. North America Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type (2015-2020)
Table 37. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 38. North America Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2015-2020)
Table 39. Europe Key Players Peripheral Arterial Disease (PAD) Therapeutics Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Peripheral Arterial Disease (PAD) Therapeutics Market Share (2019-2020)
Table 41. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type (2015-2020)
Table 43. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2015-2020)
Table 45. China Key Players Peripheral Arterial Disease (PAD) Therapeutics Revenue (2019-2020) (Million US$)
Table 46. China Key Players Peripheral Arterial Disease (PAD) Therapeutics Market Share (2019-2020)
Table 47. China Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 48. China Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type (2015-2020)
Table 49. China Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 50. China Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2015-2020)
Table 51. Japan Key Players Peripheral Arterial Disease (PAD) Therapeutics Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Peripheral Arterial Disease (PAD) Therapeutics Market Share (2019-2020)
Table 53. Japan Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type (2015-2020)
Table 55. Japan Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Peripheral Arterial Disease (PAD) Therapeutics Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Peripheral Arterial Disease (PAD) Therapeutics Market Share (2019-2020)
Table 59. Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type (2015-2020)
Table 61. Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2015-2020)
Table 63. India Key Players Peripheral Arterial Disease (PAD) Therapeutics Revenue (2019-2020) (Million US$)
Table 64. India Key Players Peripheral Arterial Disease (PAD) Therapeutics Market Share (2019-2020)
Table 65. India Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 66. India Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type (2015-2020)
Table 67. India Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 68. India Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Peripheral Arterial Disease (PAD) Therapeutics Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Peripheral Arterial Disease (PAD) Therapeutics Market Share (2019-2020)
Table 71. Central & South America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type (2015-2020)
Table 73. Central & South America Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2015-2020)
Table 75. AstraZeneca Plc. (UK) Company Details
Table 76. AstraZeneca Plc. (UK) Business Overview
Table 77. AstraZeneca Plc. (UK) Product
Table 78. AstraZeneca Plc. (UK) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020) (Million US$)
Table 79. AstraZeneca Plc. (UK) Recent Development
Table 80. Bayer HealthCare Pharmaceuticals (Germany) Company Details
Table 81. Bayer HealthCare Pharmaceuticals (Germany) Business Overview
Table 82. Bayer HealthCare Pharmaceuticals (Germany) Product
Table 83. Bayer HealthCare Pharmaceuticals (Germany) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020) (Million US$)
Table 84. Bayer HealthCare Pharmaceuticals (Germany) Recent Development
Table 85. Bristol-Myers Squibb Company (US) Company Details
Table 86. Bristol-Myers Squibb Company (US) Business Overview
Table 87. Bristol-Myers Squibb Company (US) Product
Table 88. Bristol-Myers Squibb Company (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020) (Million US$)
Table 89. Bristol-Myers Squibb Company (US) Recent Development
Table 90. Merck & Co., Inc. (US) Company Details
Table 91. Merck & Co., Inc. (US) Business Overview
Table 92. Merck & Co., Inc. (US) Product
Table 93. Merck & Co., Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020) (Million US$)
Table 94. Merck & Co., Inc. (US) Recent Development
Table 95. Proteon Therapeutics, Inc. (US) Company Details
Table 96. Proteon Therapeutics, Inc. (US) Business Overview
Table 97. Proteon Therapeutics, Inc. (US) Product
Table 98. Proteon Therapeutics, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020) (Million US$)
Table 99. Proteon Therapeutics, Inc. (US) Recent Development
Table 100. Sanofi S.A. (France) Company Details
Table 101. Sanofi S.A. (France) Business Overview
Table 102. Sanofi S.A. (France) Product
Table 103. Sanofi S.A. (France) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020) (Million US$)
Table 104. Sanofi S.A. (France) Recent Development
Table 105. Symic Bio, Inc. (US) Company Details
Table 106. Symic Bio, Inc. (US) Business Overview
Table 107. Symic Bio, Inc. (US) Product
Table 108. Symic Bio, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020) (Million US$)
Table 109. Symic Bio, Inc. (US) Recent Development
Table 110. TheraVasc Inc. (US) Business Overview
Table 111. TheraVasc Inc. (US) Product
Table 112. TheraVasc Inc. (US) Company Details
Table 113. TheraVasc Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020) (Million US$)
Table 114. TheraVasc Inc. (US) Recent Development
Table 115. AnGes MG, Inc. (Japan) Company Details
Table 116. AnGes MG, Inc. (Japan) Business Overview
Table 117. AnGes MG, Inc. (Japan) Product
Table 118. AnGes MG, Inc. (Japan) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020) (Million US$)
Table 119. AnGes MG, Inc. (Japan) Recent Development
Table 120. Athersys, Inc. (US) Company Details
Table 121. Athersys, Inc. (US) Business Overview
Table 122. Athersys, Inc. (US) Product
Table 123. Athersys, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020) (Million US$)
Table 124. Athersys, Inc. (US) Recent Development
Table 125. Betagenon AB (Sweden) Company Details
Table 126. Betagenon AB (Sweden) Business Overview
Table 127. Betagenon AB (Sweden) Product
Table 128. Betagenon AB (Sweden) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020) (Million US$)
Table 129. Betagenon AB (Sweden) Recent Development
Table 130. miRagen Therapeutics, Inc. (US) Company Details
Table 131. miRagen Therapeutics, Inc. (US) Business Overview
Table 132. miRagen Therapeutics, Inc. (US) Product
Table 133. miRagen Therapeutics, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020) (Million US$)
Table 134. miRagen Therapeutics, Inc. (US) Recent Development
Table 135. Multi Gene Vascular Systems Ltd (Israel) Company Details
Table 136. Multi Gene Vascular Systems Ltd (Israel) Business Overview
Table 137. Multi Gene Vascular Systems Ltd (Israel) Product
Table 138. Multi Gene Vascular Systems Ltd (Israel) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020) (Million US$)
Table 139. Multi Gene Vascular Systems Ltd (Israel) Recent Development
Table 140. ViroMed Co. Ltd. (Korea) Company Details
Table 141. ViroMed Co. Ltd. (Korea) Business Overview
Table 142. ViroMed Co. Ltd. (Korea) Product
Table 143. ViroMed Co. Ltd. (Korea) Revenue in Peripheral Arterial Disease (PAD) Therapeutics Business (2015-2020) (Million US$)
Table 144. ViroMed Co. Ltd. (Korea) Recent Development
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Anti-Platelet Drugs Features
Figure 3. Dual Antiplatelet Therapy Drugs Features
Figure 4. Others Features
Figure 5. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Peripheral Arterial Disease (PAD) Therapeutics Report Years Considered
Figure 10. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Regions: 2020 VS 2026
Figure 12. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Players in 2019
Figure 15. Global Top Peripheral Arterial Disease (PAD) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peripheral Arterial Disease (PAD) Therapeutics as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Peripheral Arterial Disease (PAD) Therapeutics Revenue in 2019
Figure 17. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Peripheral Arterial Disease (PAD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Peripheral Arterial Disease (PAD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Peripheral Arterial Disease (PAD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Peripheral Arterial Disease (PAD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
  • Global Medical Lighting Technology Market Size, Status and Forecast 2020-2026
    Published: 31-Jul-2020        Price: US 3900 Onwards        Pages: 130
    Medical Lighting Technology market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Medical Lighting Technology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. The key players covered in this study - Dragerwerk - Eaton Corporation......
  • Global Medical Imaging Instrument Market Insights and Forecast to 2026
    Published: 31-Jul-2020        Price: US 4900 Onwards        Pages: 145
    Medical Imaging Instrument market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Medical Imaging Instrument market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026. Segment by Type, the Medical Imaging Instrument market is segmented into - X-ray devices ......
  • Global Intrauterine Contraceptive Market Insights and Forecast to 2026
    Published: 31-Jul-2020        Price: US 4900 Onwards        Pages: 119
    Intrauterine Contraceptive market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Intrauterine Contraceptive market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026. Segment by Type, the Intrauterine Contraceptive market is segmented into - Hormonal IUCD ......
  • Global INFERTILITY TESTING AND TREATMENT Market Size, Status and Forecast 2020-2026
    Published: 31-Jul-2020        Price: US 3900 Onwards        Pages: 96
    INFERTILITY TESTING AND TREATMENT market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global INFERTILITY TESTING AND TREATMENT market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. The key players covered in this study - Merck - Procter & Gambl......
  • Global Glucose Monitoring System Market Insights and Forecast to 2026
    Published: 31-Jul-2020        Price: US 4900 Onwards        Pages: 111
    Glucose Monitoring System market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Glucose Monitoring System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026. Segment by Type, the Glucose Monitoring System market is segmented into - Sensors - Transmi......
  • Global Epigenomic Market Size, Status and Forecast 2020-2026
    Published: 31-Jul-2020        Price: US 3900 Onwards        Pages: 97
    Epigenomic market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Epigenomic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. The key players covered in this study - Roche Diagnostics - Thermo Fisher Scientific - Eisai - ......
  • Global Cosmetic Surgery and Procedures Market Size, Status and Forecast 2020-2026
    Published: 31-Jul-2020        Price: US 3900 Onwards        Pages: 127
    Cosmetic Surgery and Procedures market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cosmetic Surgery and Procedures market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. The key players covered in this study - Sanofi - Bausch Health......
  • Global Bone Graft and Substitute Market Size, Status and Forecast 2020-2026
    Published: 31-Jul-2020        Price: US 3900 Onwards        Pages: 126
    Bone Graft and Substitute market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bone Graft and Substitute market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. The key players covered in this study - Sunstar - Geistlich - Zimmer Bio......
  • Global Biologic Imaging Reagents Market Insights and Forecast to 2026
    Published: 31-Jul-2020        Price: US 4900 Onwards        Pages: 114
    Biologic Imaging Reagents market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biologic Imaging Reagents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026. Segment by Type, the Biologic Imaging Reagents market is segmented into - MRI Reagents - Ul......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs